复旦复华(600624) - 2015 Q1 - 季度财报

Financial Performance - Operating income for the period was CNY 194,306,465.26, representing a decline of 14.54% year-over-year[8] - Net profit attributable to shareholders was CNY 6,110,819.18, an increase of 6.15% compared to the same period last year[8] - Basic earnings per share decreased by 7.74% to CNY 0.0155[8] - Total operating revenue for the current period is ¥194,306,465.26, a decrease of 14.5% compared to ¥227,376,943.39 in the previous period[29] - Total operating costs decreased to ¥185,622,919.39 from ¥218,221,505.21, reflecting a reduction of 15%[29] - Operating profit increased slightly to ¥8,900,447.72, compared to ¥8,453,528.27 in the previous period, marking a growth of 5.3%[29] - Net profit for the current period is ¥7,323,199.61, up 7.7% from ¥6,798,670.16 in the previous period[30] - The net profit attributable to the parent company's shareholders is ¥6,263,911.00, an increase of 8.2% from ¥5,790,481.36[30] Cash Flow - Cash flow from operating activities increased significantly to CNY 18,042,231.19, a rise of 2147.65% year-over-year[8] - Net cash flow from operating activities increased by 21.48 times year-on-year, driven by increased cash receipts from sales and reduced cash payments for goods and services.[16] - Cash inflow from operating activities totaled 34,005,088.61 RMB, significantly up from 15,691,970.77 RMB in the previous year, indicating a 116.5% increase[38] - Cash outflow from operating activities increased to 102,971,770.35 RMB from 7,647,204.01 RMB, reflecting a substantial rise in operational expenses[38] - Cash inflow from investment activities totaled ¥46,330,126.59, with cash outflow for fixed assets and other long-term assets at ¥46,856,354.75[35] - The company reported an investment income of ¥216,901.85, recovering from a loss of ¥701,909.91 in the previous period[29] - The net cash flow from financing activities improved to 8,672,718.07 RMB from -11,801,500.00 RMB, indicating a positive shift in financing operations[39] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,649,945,660.08, a decrease of 0.26% compared to the end of the previous year[8] - Current assets totaled CNY 730,674,135.57, down from CNY 778,646,542.65, representing a decrease of about 6.16%[22] - Non-current assets increased to CNY 919,271,524.51 from CNY 875,593,540.55, reflecting a growth of approximately 4.97%[22] - Total liabilities decreased to CNY 557,310,539.70 from CNY 567,925,332.54, a reduction of about 1.08%[23] - Current liabilities totaled CNY 307,964,960.39, down from CNY 332,204,253.23, indicating a decrease of approximately 7.25%[23] - Owner's equity increased to CNY 1,092,635,120.38 from CNY 1,086,314,750.66, showing an increase of about 0.59%[23] - The total liabilities and owner's equity amounted to CNY 1,093,095,789.21, down from CNY 1,145,663,348.60, reflecting a decrease of approximately 4.58%[26] Shareholder Information - The total number of shareholders at the end of the reporting period was 53,969[10] - The company reported a net asset per share of CNY 2.547, up 0.59% from the previous year[8] Other Financial Metrics - Cash and cash equivalents increased by 95.36% year-on-year, mainly due to the increase in net cash flow from operating activities and a significant reduction in cash outflows from financing activities.[18] - Cash paid for the acquisition of fixed assets, intangible assets, and other long-term assets increased by 70.94% year-on-year, reflecting increased investment in fixed assets.[16] - Cash inflows from investment activities increased by 100% year-on-year, primarily due to cash recovery from investments and investment income received.[16] - Operating tax and additional fees increased by 69.56% year-on-year, mainly due to increased VAT payable by subsidiary Fudan Fuhua Pharmaceutical Co., Ltd.[15] - Financial expenses decreased by 80.39% year-on-year, primarily due to a reduction in short-term borrowings compared to the same period last year.[15]